- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/36 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Patent holdings for IPC class C07C 235/36
Total number of patents in this class: 46
10-year publication summary
0
|
5
|
3
|
3
|
5
|
2
|
3
|
2
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 20565 |
4 |
Symrise AG | 1693 |
4 |
Abbvie Inc. | 1789 |
2 |
Flexus Biosciences, Inc. | 13 |
2 |
Monash University | 698 |
2 |
Musc Foundation for Research Development | 339 |
2 |
New York University | 1702 |
2 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2849 |
2 |
Calico Life Sciences LLC | 86 |
2 |
L' Oréal | 5346 |
2 |
L'OREAL, Société Anonyme | 15195 |
1 |
Novartis AG | 11221 |
1 |
Bristol-myers Squibb Company | 4875 |
1 |
Boehringer Ingelheim International GmbH | 4750 |
1 |
Bayer AG | 3238 |
1 |
Sumitomo Chemical Company, Limited | 8990 |
1 |
The Johns Hopkins University | 5562 |
1 |
Takeda Pharmaceutical Company Limited | 2938 |
1 |
AnalytiCon Discovery GmbH | 33 |
1 |
Aurimmed Pharma, Inc. | 7 |
1 |
Other owners | 12 |